Mitigation at che clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers
Sm. Ng et al., Mitigation at che clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers, AM J CARD, 87(8), 2001, pp. 994-999
Citations number
26
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
The ability to differentiate between true positives, false positives, and s
poradically elevated cardiac troponin levels has grown in importance as car
diac troponins assume an increasingly dominant role in the diagnosis of cor
onary syndromes. In a population sample of 1,000 patients who presented con
secutively to a large urban hospital emergency room, 50 of 112 patients who
had elevated troponin levels (>0.6 ng/ml) during evaluation for myocardial
injury were subsequently found to have had an isolated, spurious elevation
of cardiac troponin, and not a diagnosed myocardial infarction, Logistic r
egression analysis shows that by hierarchically analyzing electrocardiograp
hic changes with concurrent creating kinase-MB and myoglobin levels at the
time of the troponin elevation, one may predict with 91% accuracy whether t
he troponin elevation is actually indicative of a myocardial infarction in
a patient. Spurious troponin elevations may be a common occurrence, and if
not detected, may result in on increased number of falsely diagnosed myocar
dial infarctions. (C) 2001 by Excerpta Medica, Inc.